The hope, hype and obstacles surrounding cell therapy.

Area of Science:

• Regenerative Medicine
• Cell Therapy
• Synthetic Biology

Background:

• Limited regenerative capacity of human organs and tissues hinders healing of irreversible diseases.
• Stem cells and derivatives face challenges in addressing diseases with permanent pathophysiological changes.
• Regenerative medicine shows potential for conditions like type one diabetes and Parkinson's disease, but not all diseases.

Purpose of the Study:

• To explore the challenges and potential of cell therapy and regenerative medicine.
• To discuss the limitations in treating irreversible diseases and hereditary conditions.
• To highlight the emerging role of synthetic biology and specific therapies like CAR-T.

Main Methods:

• Review of current limitations in cell therapy and regenerative medicine.
• Analysis of disease types amenable and not amenable to current regenerative approaches.
• Exploration of future directions including synthetic biology and CAR-T therapy.

Main Results:

• Cell therapy faces significant hurdles in regenerating tissues damaged by irreversible conditions.
• Current regenerative medicine cannot eliminate the root cause of many diseases, particularly hereditary ones and ciliopathies.
• Synthetic biology presents potential solutions, though implementation is years away; CAR-T therapy offers a current success example.

Conclusions:

• Significant challenges remain in cell therapy and regenerative medicine for irreversible and complex genetic diseases.
• While promising for some conditions, these therapies cannot address all disease etiologies.
• Future advancements in synthetic biology and targeted therapies like CAR-T are crucial for expanding treatment possibilities.